Osteosarcoma risk factors: Difference between revisions
Jump to navigation
Jump to search
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Osteosarcoma}} | {{Osteosarcoma}} | ||
{{CMG}}; {{AE}}[[User:DrMars|Mohammadmain Rezazadehsaatlou[2]]] | {{CMG}}; {{AE}} [[User:DrMars|Mohammadmain Rezazadehsaatlou[2]]] | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of osteosarcoma are [[Radiation therapy|radiation]] to bones, [[alkylating antineoplastic agents]], [[Paget disease]], multiple hereditary [[osteochondromas]], [[fibrous dysplasia]], [[Bloom syndrome]],[[Rothmund-Thomson syndrome]], and [[Li-Fraumeni syndrome]]. | Common risk factors in the development of [[osteosarcoma]] are [[Radiation therapy|radiation]] to bones, [[alkylating antineoplastic agents]], [[Paget disease]], multiple hereditary [[osteochondromas]], [[fibrous dysplasia]], [[Bloom syndrome]],[[Rothmund-Thomson syndrome]], and [[Li-Fraumeni syndrome]]. | ||
==Risk Factors == | ==Risk Factors == | ||
=== Common Risk Factors === | === Common Risk Factors === | ||
* The most common [[risk factors]] for [[osteosarcoma]] include:<ref name="pmid27986268">{{cite journal |vauthors=Stern N, Sakji I, Defachelles AS, Lervat C, Ryckewaert T, Marliot G, Peugniez C, Deplanque D, Penel N |title=[Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients] |language=French |journal=Bull Cancer |volume=104 |issue=3 |pages=208–212 |date=March 2017 |pmid=27986268 |doi=10.1016/j.bulcan.2016.11.007 |url=}}</ref><ref name="pmid27860191">{{cite journal |vauthors=Endicott AA, Morimoto LM, Kline CN, Wiemels JL, Metayer C, Walsh KM |title=Perinatal factors associated with clinical presentation of osteosarcoma in children and adolescents |journal=Pediatr Blood Cancer |volume=64 |issue=6 |pages= |date=June 2017 |pmid=27860191 |doi=10.1002/pbc.26349 |url=}}</ref><ref name="pmid23824394">{{cite journal |vauthors=Miller BJ, Cram P, Lynch CF, Buckwalter JA |title=Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database |journal=J Bone Joint Surg Am |volume=95 |issue=13 |pages=e89 |date=July 2013 |pmid=23824394 |pmc=3689260 |doi=10.2106/JBJS.L.01189 |url=}}</ref><ref name="pmid26400284">{{cite journal |vauthors=Zhang HF, Yan JP, Zhuang YS, Han GQ |title=Association between angiogenic growth factor genetic polymorphisms and the risk of osteosarcoma |journal=Genet. Mol. Res. |volume=14 |issue=3 |pages=10524–9 |date=September 2015 |pmid=26400284 |doi=10.4238/2015.September.8.14 |url=}}</ref> | |||
* The most common risk factors for [[osteosarcoma]] include:<ref name="pmid27986268">{{cite journal |vauthors=Stern N, Sakji I, Defachelles AS, Lervat C, Ryckewaert T, Marliot G, Peugniez C, Deplanque D, Penel N |title=[Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients] |language=French |journal=Bull Cancer |volume=104 |issue=3 |pages=208–212 |date=March 2017 |pmid=27986268 |doi=10.1016/j.bulcan.2016.11.007 |url=}}</ref><ref name="pmid27860191">{{cite journal |vauthors=Endicott AA, Morimoto LM, Kline CN, Wiemels JL, Metayer C, Walsh KM |title=Perinatal factors associated with clinical presentation of osteosarcoma in children and adolescents |journal=Pediatr Blood Cancer |volume=64 |issue=6 |pages= |date=June 2017 |pmid=27860191 |doi=10.1002/pbc.26349 |url=}}</ref><ref name="pmid23824394">{{cite journal |vauthors=Miller BJ, Cram P, Lynch CF, Buckwalter JA |title=Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database |journal=J Bone Joint Surg Am |volume=95 |issue=13 |pages=e89 |date=July 2013 |pmid=23824394 |pmc=3689260 |doi=10.2106/JBJS.L.01189 |url=}}</ref><ref name="pmid26400284">{{cite journal |vauthors=Zhang HF, Yan JP, Zhuang YS, Han GQ |title=Association between angiogenic growth factor genetic polymorphisms and the risk of osteosarcoma |journal=Genet. Mol. Res. |volume=14 |issue=3 |pages=10524–9 |date=September 2015 |pmid=26400284 |doi=10.4238/2015.September.8.14 |url=}}</ref> | |||
** Teenage [[growth spurts]] | ** Teenage [[growth spurts]] | ||
** Being tall | ** Being tall | ||
** Previous treatment with [[radiation]] for another cancer, especially at a young age or with high doses of [[radiation]]. | ** Previous treatment with [[radiation]] for another [[cancer]], especially at a young age or with high [[Dose|doses]] of [[radiation]]. | ||
** Drugs: past treatment with anticancer drugs called [[alkylating antineoplastic agents]]. | ** Drugs: past treatment with [[Anticancer agents|anticancer]] drugs called [[alkylating antineoplastic agents]]. | ||
* Presence of certain [[benign]] (noncancerous) bone diseases, such as: | * Presence of certain [[benign]] (noncancerous) bone diseases, such as: | ||
| Line 26: | Line 23: | ||
=== Less Common Risk Factors === | === Less Common Risk Factors === | ||
* Less common risk factors in the development of [[osteosarcoma]] include: | * Less common risk factors in the development of [[osteosarcoma]] include: | ||
# [[Bloom syndrome]] | # [[Bloom syndrome]] | ||
#[[Diamond-Blackfan anemia]] | #[[Diamond-Blackfan anemia]] | ||
Latest revision as of 18:28, 19 October 2019
|
Osteosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteosarcoma risk factors On the Web |
|
American Roentgen Ray Society Images of Osteosarcoma risk factors |
|
Risk calculators and risk factors for Osteosarcoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammadmain Rezazadehsaatlou[2]
Overview
Common risk factors in the development of osteosarcoma are radiation to bones, alkylating antineoplastic agents, Paget disease, multiple hereditary osteochondromas, fibrous dysplasia, Bloom syndrome,Rothmund-Thomson syndrome, and Li-Fraumeni syndrome.
Risk Factors
Common Risk Factors
- The most common risk factors for osteosarcoma include:[1][2][3][4]
- Teenage growth spurts
- Being tall
- Previous treatment with radiation for another cancer, especially at a young age or with high doses of radiation.
- Drugs: past treatment with anticancer drugs called alkylating antineoplastic agents.
- Presence of certain benign (noncancerous) bone diseases, such as:
- Paget disease of bone
- Multiple hereditary osteochondromas
- Fibrous dysplasia
- Enchondromatosis
Less Common Risk Factors
- Less common risk factors in the development of osteosarcoma include:
- Bloom syndrome
- Diamond-Blackfan anemia
- Familial adenomatous polyposis
- Li-Fraumeni syndrome
- Hereditary retinoblastoma
- Rothmund-Thomson syndrome
- Werner syndrome
References
- ↑ Stern N, Sakji I, Defachelles AS, Lervat C, Ryckewaert T, Marliot G, Peugniez C, Deplanque D, Penel N (March 2017). "[Incidence and risk factors for ifosfamide-related encephalopathy in sarcoma patients]". Bull Cancer (in French). 104 (3): 208–212. doi:10.1016/j.bulcan.2016.11.007. PMID 27986268.
- ↑ Endicott AA, Morimoto LM, Kline CN, Wiemels JL, Metayer C, Walsh KM (June 2017). "Perinatal factors associated with clinical presentation of osteosarcoma in children and adolescents". Pediatr Blood Cancer. 64 (6). doi:10.1002/pbc.26349. PMID 27860191.
- ↑ Miller BJ, Cram P, Lynch CF, Buckwalter JA (July 2013). "Risk factors for metastatic disease at presentation with osteosarcoma: an analysis of the SEER database". J Bone Joint Surg Am. 95 (13): e89. doi:10.2106/JBJS.L.01189. PMC 3689260. PMID 23824394.
- ↑ Zhang HF, Yan JP, Zhuang YS, Han GQ (September 2015). "Association between angiogenic growth factor genetic polymorphisms and the risk of osteosarcoma". Genet. Mol. Res. 14 (3): 10524–9. doi:10.4238/2015.September.8.14. PMID 26400284.